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Abstract 1 
INTRODUCTION: Toll-like receptor (TLR) activity within gestation-associated tissues might have 2 
a role in normal pregnancy progression as well as adverse obstetric outcomes such as preterm 3 
birth (PTB).  4 
 5 
METHODS: The expression and activity of TLRs 1 – 9 in placentas collected following preterm 6 
vaginal delivery after infection-associated preterm labour (IA-PTL) at 25 – 36 weeks of gestation 7 
(preterm-svd, n = 10) were compared with those obtained after normal vaginal delivery at term 8 
(term-laboured; n=17).  Placental explants were cultured in the presence of agonists for TLR2, 9 
3, 4, 5, 7, 8 and 9 and cytokine production after 24 hours examined. Expression of TLR 10 
transcripts was determined using real time quantitative PCR.  11 
 12 
RESULTS: Reactivity to all agonists except CpG oligonucleotides was observed indicating that 13 
other than TLR9 all of the receptors studied yielded functional responses both term and 14 
preterm. Significantly less TNFα and IL-6, but not IL-10, were produced by preterm than term 15 
samples in response to all TLR agonists. Changes in TLR mRNA expression did not underlie 16 
functional differences in the preterm and term groups; nor does a pre-exposure/tolerance 17 
model mimic this finding. While glucocorticoids suppressed cytokine production in an in vitro 18 
model using term tissue the association between lower gestational age and decreased cytokine 19 
outputs suggests a temporally regulated response.  20 
 21 
DISCUSSION: Pro-inflammatory cytokine output in response to multiple TLR ligands was 22 
decreased in the preterm compared to the term placenta but gene expression for each TLR 23 
tended to be similar. Reduced cytokine production by the preterm placenta in response to 24 
stimulation of TLRs therefore must be regulated at the post-transcriptional level in a 25 
gestational age dependent manner.  26 
 27 
 28 
 29 
 30 
 31 
 32 
 3
 33 
 34 
Introduction 35 
Cytokines and chemokines have a role in the normal physiological processes of pregnancy 36 
including parturition. IL-1β, IL-6, IL-8 and TNFα among others are produced by gestation-37 
associated tissues both constitutively and/or in response to insult (1, 2). This has led to interest 38 
in the mechanisms of cytokine production in these tissues, with signalling pathways of the 39 
innate immune system that produce a defined cytokine output postulated as central to this (3). 40 
Toll-like receptors (TLRs), a family of pattern recognition receptors (PRRs), link microbial 41 
agonists to the production of inflammatory mediators. In humans, ten TLRs (TLRs 1 -10) have 42 
been identified (4). TLRs could provide a mechanism of cytokine production at the maternal-43 
fetal interface in not only normal physiological aspects of pregnancy but also in various 44 
pathological states of pregnancy such as infection associated preterm labour (3, 5).  45 
 46 
The placenta has been called a pregnancy-specific component of the innate immune system 47 
because it constitutes a physical and immunological barrier against invading infectious agents; 48 
the activity of TLRs and other PRRs within cells of the placenta would support such a role. 49 
Transcripts for TLRs 1-10 have been demonstrated in both the term and preterm human 50 
placenta and isolated cytotrophoblast and syncytiotrophobasts (6, 7). Trophoblastic 51 
choriocarcinoma cell lines express TLRs 1-10 and several co-receptors and accessory proteins 52 
(8). Functional activity of TLR2, TLR3 and TLR4 has been reported for first and third trimester 53 
trophoblast/placenta (9-12) and choriocarcinoma cell lines are responsive to ligands for TLRs 2, 54 
3, 4 and 9 (8). Other cell types within the term placenta including Hofbauer cells express TLR2, 55 
TLR3 and TLR4 mRNA and/or protein and have functionally active TLR3 and TLR4 (13, 14). There 56 
is temporal variation in the expression of TLRs in the placenta: both first trimester primary 57 
trophoblast and trophoblast cell lines express TLRs 1-4 but not TLR6 which is expressed in third 58 
trimester trophoblast (9, 15), while TLR4 expression is higher at term than during the first 59 
trimester (16).  60 
 61 
Globally around 10% or babies are born prematurely. There are three main antecedents of PTB: 62 
30 – 35% maternal or fetal indications, 40 – 45% spontaneous preterm labour with intact 63 
membranes, and 20 – 25% preterm premature rupture of the membranes (PPROM): the latter 64 
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two are grouped as spontaneous PTB (17). Pathophysiological mechanisms underlying 65 
spontaneous PTB are largely unknown but a wealth of evidence indicates that preterm labour is 66 
an inflammatory process (18, 19). The induced inflammatory milieu is likely heterogeneous 67 
depending on the underlying cause of PTB (18, 20), and both gestation-associated tissues 68 
themselves and infiltrating leukocytes contribute (21). However, there is little information 69 
about the possible role of PRRs and their ligands in spontaneous PTB especially that associated 70 
with infection. The probable role of TLRs in the pathogenesis of infection-associated preterm 71 
labour (IA-PTL) and other adverse pregnancy outcomes has been studied mostly with regards 72 
to TLR4: inflammatory cells infiltrating preterm placentas with chorioamnionitis express TLR4, 73 
and TLR4 expression on villous Hofbauer cells is increased in preterm placentas without 74 
chorioamnionitis and term placentas (14); functional TLR4 has been implicated in preterm 75 
labour triggered by administration of heat killed E.coli in mice (22); expression of TLRs 2, 4, 5 76 
and 6 mRNA and TLR4 protein are also increased in the preeclamptic placenta (23, 24); the 77 
Asp299Gly TLR4 gene polymorphism associated with impaired TLR4 receptor function and an 78 
increased likelihood of Gram-negative sepsis (25) is carried more often by preterm than term 79 
infants or by mothers delivering preterm rather than at term (26).  A role for functional TLR3 in 80 
preterm labour also has been described (27). Evidence for a role for TLRs in infection-81 
associated preterm birth also comes from genetic studies.  82 
 83 
Over the past few years there has been a dramatic increase in interest and information about 84 
activity mediated by microbial ligands/TLR combinations in various tissues and diseases. As we 85 
had previously described that multiple TLRs (with the exception of TLR9) were functional in the 86 
term placenta and stimulation with TLR agonists could lead to the production of relevant 87 
cytokines and chemokines (6) an investigation of the expression and activity of TLRs in preterm 88 
placentas delivered with evidence of intrauterine infection was undertaken.  89 
 90 
 91 
92 
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Materials and Methods 93 
Characteristics of preterm samples   94 
Placentas were obtained following preterm labour at varying gestations, ranging from 25 weeks 95 
to 36 weeks (n=15; Table 1). The 10 cases which delivered vaginally after spontaneous onset of 96 
labour had no evidence of preeclampsia, intrauterine growth restriction or other obvious 97 
materno-fetal reasons but evidence of infection was found in all but one either in the form of 98 
histologic chorioamnionitis, positive swabs, urine examination or blood markers of infection 99 
(Table 1); all women had received steroid injections as part of their clinical care. None of these 100 
women were known to have any autoimmune or other immunological disorders. These cases 101 
(n=10) (IA-PTL) have been included in this study. Gestational age was calculated by ultrasound 102 
or by the first day of the last menstrual period. Women were approached either at admission in 103 
early labour or soon after delivery in full liaison with the midwives. Term samples were from 104 
women who delivered vaginally after spontaneous onset of  labour and after 37 completed 105 
weeks of gestation. All women delivering preterm had received steroids prior to delivery as 106 
part of their clinical therapy for preterm labour; women delivering at term had not. All women 107 
gave informed written consent and Wales Research Ethics Committee 6 approved the study.  108 
 109 
Placental explant culture 110 
All placentas were weighed and then explant cultures were prepared as described [23]. Briefly, 111 
the overlaying decidua basalis on the maternal side of the placenta was removed and 1 cm
3
 112 
pieces of placental tissue were taken from different sites across the placenta and placed into 113 
sterile Ca
++
/Mg
++
 free phosphate buffered saline (PBS; Life Technologies, UK). Care was taken to 114 
avoid contamination with chorioamnion. Tissue was washed repeatedly with PBS to remove 115 
contaminating blood and was then minced into smaller pieces (approximately 1-2 mm
3
). Pieces 116 
of minced placental tissue (0.5 g in total) were transferred into each well of a 6-well tissue 117 
culture plate (Greiner Bio-one, Germany) containing 2.5 mls of Ultraculture medium (Cambrex, 118 
Belgium) supplemented with
 
2mM Glutamax (Life Technologies) and 100 U/ml Penicillin G, 100 119 
µg/ml streptomycin sulphate and 0.25 µg/ml amphotericin B (PSF; Life Technologies). Care was 120 
taken to avoid any blood clots or fibrous tissue.  121 
 122 
Optimal levels of all agonists were determined for the following final concentrations: 123 
peptidoglycan (PGN; TLR2, 3 µg/ml); poly I:C (TLR3, 25 µg/ml); LPS (TLR4, 100 ng/ml); flagellin 124 
 6
(TLR5, 100 ng/ml); R848 (TLR7/8, 100 ng/ml); loxoribine (TLR7/8, 100 µM); single stranded 125 
polyU/LyoVEC complexes (ssPoly, TLR7/8, 1 µg/ml); ODN2216 CpG (TLR9, 1 µM) and control 126 
ODN (all from Invivogen). An unstimulated control was always included. Plates were incubated 127 
at 37°C in 5% CO2 for 24 hours. Cell/tissue free culture supernatants were collected by 128 
centrifugation
 
and stored at -20°C until assayed. 129 
 130 
Placental explant cultures prepared from placentas obtained following elective caesarean 131 
section at term were: (i) treated with the optimised concentration of each TLR ligand, then 132 
after incubation at 37
o
C for 24 hours, the tissue was washed by centrifugation and re-cultured 133 
for 24 hours in fresh media containing concentrations of TLR ligands as indicated in the results; 134 
(ii) treated with the optimised concentration of each TLR ligand alone and in the presence of 135 
0.4, 4 or 40 ng/ml dexamethasone (Sigma, USA) for 20 - 24 hours. Supernatants were harvested 136 
and stored at -20
o
C until analysis of IL-6 levels by ELISA. 137 
 138 
Extreme care was taken to limit endotoxin contamination during explant preparation. These 139 
precautions included the use of disposable plastic-ware and other consumables (e.g. scissors) 140 
whenever possible (28). All media/reagents were tested by the manufacturers and reported as 141 
endotoxin free. 142 
 143 
Real time quantitative PCR (qPCR) 144 
Placental biopsies were preserved in RNAlater
®
 (Sigma, Poole, UK) at -80°C. Preparation of 145 
DNA-free RNA from homogenised tissue and reverse transcription were performed as 146 
described in detail previously (6). Confirmation of genomic DNA-free status and successful 147 
reverse transcription was obtained by PCR amplification of the S15 ribosomal protein gene. 148 
Real-time PCR for all genes of interest (TLR 1-10) and 3 housekeeping genes was carried out 149 
using the iCycler IQ (ver.3.1 Bio-Rad). The house keeping genes, succinate dehydrogenase 150 
complex subunit A (SDHA), TATA box binding protein (TBP) and tyrosine 3-151 
monooxygenase/tryptophan 5-monooxygenase activation protein zeta polypeptide (YWHAZ) 152 
were selected as they are the most stably expressed in the human placenta (29). Primer 153 
sequences and the specific conditions particular to each PCR are listed in Table 2 with further 154 
details as described previously (6).  155 
 156 
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Enzyme linked immunosorbent assay (ELISA)  157 
TNFα, IL-6, and IL-10 in supernatants from placental explant cultures were measured using 158 
commercial ELISA
 
kits according to the manufacturer’s instructions (OptEIA; BDBiosciences). The 159 
sensitivity of each of the ELISAs varied between 1 and 4pg/ml and the intra- and inter-assay 160 
coefficients of variation were <10%. 161 
 162 
Statistical analysis 163 
The Mann Whitney U test for two independent samples was used to compare TLR expression 164 
and activity; for the dexamethasone experiments the Friedmans test with Dunn multiple 165 
comparison posthoc test was used (GraphPad Prism Version 6, GraphPad Software Inc, USA).  166 
 167 
 168 
169 
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Results 170 
Comparison of TLR activity between the IA-PTL group and the term laboured group 171 
Comparison of the cytokine outputs from the 10 placentae obtained following suspected IA-PTL 172 
was made with term-laboured group (Figure 1 a – g). The concentration of TNFα and/or IL-6 173 
was statistically significantly reduced in preterm samples (n = 10) compared with term samples 174 
(n = 17) treated with PGN (TLR2) poly I:C (TLR3), LPS (TLR4), flagellin (TLR5), R848 (TLR7/8) but 175 
not zymosan or loxoribine (TLR7/8) (p values shown on graphs). None of the preterm or term 176 
samples responded to CpG for the cytokines measured in this study. Constitutive production of 177 
IL-6 was also significantly reduced in the preterm samples (p = 0.02; Figure 1 h). In contrast, 178 
irrespective of the TLR ligand used, IL-10 production did not differ significantly between term 179 
and preterm samples.  180 
 181 
 182 
Comparison of mRNA for TLR1 - TLR10 between term laboured and preterm laboured groups. 183 
Placental biopsies from all deliveries were placed in RNAlater
®
 and RNA extraction, cDNA 184 
synthesis and PCR were conducted as mixed batches (preterm and term). The expression of TLR 185 
transcripts by the two groups did not differ statistically for any of the TLRs (Figures 2 a – j; p 186 
values shown on graphs).  187 
 188 
Effect of pre-exposure to TLR ligands on TLR ligand stimulated cytokine output of placental 189 
explants  190 
As all but one of the 10 preterm-SVD placentas came from deliveries with evidence of 191 
intrauterine infection it was possible that they were exposed in utero to one or more of the TLR 192 
ligands used in this study. Pre-exposure to LPS is known to reduce the level of response upon 193 
secondary exposure to LPS, a process known as endotoxin tolerance (30). Therefore it was 194 
postulated that pre-exposure to any one ligand could explain the reduced cytokine outputs (at 195 
least for IL-6 and TNFα) in response to all ligands in the preterm group. Therefore, placental 196 
explants prepared from term non-laboured placenta were exposed to each TLR ligand and after 197 
24 hours culture the first dose of ligand was removed by centrifugation and the tissue re-198 
cultured in fresh medium in the presence of the same or another TLR ligand. After a further 24 199 
hours culture, supernatants were harvested and analysed for IL-6. Data obtained for 200 
unstimulated, LPS-, PGN- and flagellin-treated samples are shown (Figure 3 a-d).  There was no 201 
consistent trend in the cytokine output but reduced outputs were not an overarching feature.  202 
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Effect of dexamethasone and gestational age on cytokine output of preterm placental explants  203 
As all the women in the IA-PTL group received steroids prior to delivery as part of their clinical 204 
therapy for preterm labour, the effect of dexamethasone (steroid) treatment on TLR-205 
stimulated cytokine output by the placenta was explored. Placental explants prepared from 206 
non-laboured term deliveries (elective caesarean section) were treated with dexamethasone 207 
and IL-6 outputs in response to all TLR ligands determined. IL-6 was chosen as it can be induced 208 
by all ligands studied and is produced constitutively. Constitutive and TLR ligand-stimulated IL-6 209 
was reduced in the presence of dexamethasone for all TLR ligands studied (only constitutive 210 
and the response to PGN, Poly (I:C), LPS and flagellin are shown; Figure 4a). The reduction in 211 
the cytokine output following treatment with 40 ng/ml dexamethasone was significant with p < 212 
0.05 for ligand-stimulated explants (with the exception of flagellin).  Given all women who 213 
delivered preterm had been administered corticosteroids prior to delivery and the in vitro 214 
steroid use model showed decreased responses via TLRs upon steroid exposure we also 215 
considered the impact of gestational age alone on the response. Figure 4b shows that 216 
decreasing gestational age is associated with decreasing LPS-stimulated IL-6, even when 217 
mothers have been administered coroticosteroids, suggesting that the reduced TLR ligand 218 
response by the preterm placenta is a consequence of gestational age and not steroid 219 
exposure.   220 
 221 
 222 
 223 
 224 
 225 
 226 
 227 
 228 
 229 
 230 
 231 
 232 
 233 
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 234 
 235 
Discussion 236 
IL-6 and TNFα but not IL-10 outputs after stimulation of the placenta with TLR2, TLR3, TLR4, 237 
TLR5 and TLR7/8 ligands were significantly reduced in the preterm compared with the term 238 
laboured group. TLR9 activity was not detected in either group. Despite these functional 239 
differences on comparison with the term group there were no differences in the levels of 240 
mRNA for any of the TLRs studied. This is similar to our results obtained for term laboured 241 
placentae versus term non-laboured placentae, in which there was no apparent correlation 242 
between functional output and mRNA levels for any of the TLRs (6). These results suggest that 243 
TLR protein expression should be studied in greater detail and/or that negative regulators of 244 
TLR-dependent signalling might have a critical role. A number of inhibitors of TLR-mediated 245 
activity have now been described. Over-expression of Tollip (toll interacting protein) results in 246 
impaired NF-κB activation which can diminish the TLR response and thereby the associated 247 
cytokine output (31). Similarly, SIGGR (single immunoglobulin IL-1R-related molecule) acts as a 248 
negative regulator of interleukin (IL)-1 and lipopolysaccharide (LPS) signalling (32, 33). Also, the 249 
placenta is an abundant source of suppressor of cytokine signalling 1 (SOCS-1), with 3-fold 250 
greater gene expression than the spleen (34), and SOCS-1 protein has been identified as a 251 
negative regulator of TLR signalling (35). Investigation of the relative expression of these 252 
inhibitors in preterm versus term tissues might prove fruitful. 253 
One of the challenges of undertaking studies such as this in humans is that samples tend to be 254 
only accessible once labour is completed (although this might not be the case in emergency 255 
caesarean sections). Consequently, results obtained using the samples for this study might not 256 
be representative of the response occurring in utero prior to or earlier in labour. All but one of 257 
the preterm deliveries had evidence of infection so the possibility that previous stimulation of a 258 
TLR (i.e. in utero) might down-regulate secondary responses (i.e. in vitro) was considered. This 259 
could be because of exhaustion or down regulation of the relevant TLR pathways in vivo as a 260 
result of response to the presence of infection. Pre-exposure to LPS is known to reduce the 261 
level of response upon secondary exposure to LPS, a process known as endotoxin tolerance 262 
(36, 37). Endotoxin tolerance is a well-known phenomenon, described both in vivo and in vitro, 263 
in which repeated exposure to endotoxin results in a diminished response, usually 264 
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characterised as a reduction in pro-inflammatory cytokine release. With increasing 265 
understanding of the part played by TLR4 signalling in endotoxin release it has become clear 266 
that tolerance occurs to other TLR ligands in addition to endotoxin (36). To test this as an 267 
explanation for the lower IL-6 and TNFα responses in preterm samples we used term non-268 
laboured placentas from elective caesarean sections and treated them in vitro with the study 269 
TLR ligands, washed the tissue, and then re-exposed it to the TLR ligands. There was no 270 
evidence of diminished response to any TLR ligand on secondary exposure. While a more 271 
sophisticated model might yield contrasting results our findings suggest that prior intrauterine 272 
exposure to the ligand does not explain the reduced cytokine output of preterm placental 273 
explants in comparison to term explants.  274 
Women in preterm labour are treated with various pharmacotherapies to try and halt 275 
premature labour (tocolytics) but also to prepare the baby for premature delivery 276 
(corticosteroids). As corticosteroids are known to down-regulate inflammatory responses (38, 277 
39) the possibility that corticosteroids might explain the findings was considered. Constitutive 278 
and TLR ligand-stimulated IL-6 was reduced in the presence of dexamethasone for all TLR 279 
ligands so prior exposure to steroids in the preterm group could contribute to reduced TLR 280 
function in these samples. However, as decreasing gestational age seems to associated with 281 
decreasing TLR-stimulated cytokine output, even with corticosteroid exposure, it is likely that 282 
gestational age is the overriding factor modulating the placental inflammatory response. This 283 
needs to better understood if we are to elucidate the role of the inflammatory response in 284 
preterm labour.  285 
While TLRs were the focus here, other families of PRRs have been described including NOD-like 286 
receptors (NLRs), RIG-I-like receptors (RLRs), C-type lectin receptors (CLRs) and cytosolic DNA 287 
sensors (CDS), that may contribute to the mechanisms of cytokine production at the maternal-288 
fetal interface (5). However, to date only NLR activity has been examined in the placenta with 289 
both NOD1 and NOD2 expressed in the first trimester placenta where they are localised to the 290 
syncytiotrophoblast and cytotrophoblast; only NOD1 is expressed in term trophoblast cells (40, 291 
41). This corresponds to the functional outputs of first versus third trimester trophoblast cells; 292 
first trimester cells respond to both iE-DAP (γ-D-Glu-mDAP; NOD1 ligand) and MDP (muramyl 293 
dipeptide; NOD2 ligand), while third trimester cells only respond to iE-DAP (42) which can 294 
induce preterm delivery in a murine model (43). Certain NLRs with ASC (apoptosis-associated 295 
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speck-like protein containing a CARD) and caspase-1 can form the inflammasome for the 296 
processing and secretion of IL-1β and IL-18 (44). Several of these NLRs, including NLRP1, NLRP3 297 
and NLRC4 are expressed in first trimester cytotrophoblasts with their expression enhanced 298 
and IL-1β induced in the presence of LPS (45). 299 
This work clearly demonstrates that the human preterm placenta expresses functional TLR2, 3, 300 
4, 5, and 7/8. However contradictory to the assumption that infection-associated preterm 301 
labour would be associated with enhanced cytokine levels secondary to its infection related 302 
etiology, we found reduced cytokine output in the preterm samples in comparison to term 303 
samples. This does not appear to result from a mechanism similar to endotoxin tolerance and 304 
whilst it could reflect exposure to steroids this reduced output by the preterm placenta might 305 
also be due to over expression of TLR inhibitors or post-transcriptional modification of TLR 306 
expression. Unfortunately, samples of placental membranes were not included in this study but 307 
the response by them might differ to that by the placenta. Further studies are required to 308 
consider spatial differences in TLR and other PRR expression and function with investigation of 309 
the expression of inhibitors of TLR activity particularly worthwhile pursuing. 310 
 311 
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Figure Legends 
 
Figure 1.  Comparison of cytokine outputs (TNFα, IL-6 and IL-10) from placental explants of 
term-laboured  (n=17) versus preterm-svd (n =10)  in response to (a) PGN, (b) LPS, (c) flagellin, 
(d) zymosan, (e) R848 (f) poly I:C, and (g) loxoribine; IL-6 levels produced constitutively are also 
shown (h). Mann Whitney U test for two independent samples was employed for statistical 
analysis; p < 0.05 was considered significant. (
o
 denotes outliers) 
 
Figure 2. TLR transcript expression in term and preterm placentas. Box and whisker plots 
depicting comparison between expression of mRNA for TLRs 1-10 in the term-laboured (T) 
(n=12) and preterm-SVD (P) (n = 10) groups. Mann Whitney U test for two independent 
samples was employed and the p values are shown on the graphs. 
 
Figure 3. Effect of pre-exposure to TLR ligands on TLR ligand stimulated cytokine output of 
placental explants. Explants were prepared from term non-laboured placentas and treated with 
TLR ligands, as indicated on each figure for 24 hours. After washing the tissue it was re-cultured 
in the presence of the same or different ligand as indicated on the figure. Supernatants were 
harvested after a further 24 hours and IL-6 production in response to (a) constitutive (Cons)/no 
stimulation, (b) LPS, (c) PGN, (d) Flagellin for first 20 - 24 hours then no, flagellin, LPS or PGN 
stimulation of the second 20 – 24 hours determined by ELISA (n = 3; mean ± SEM).  
 
Figure 4.  Effect of dexamethasone and gestational age on IL-6 production by placenta. (a) 
Placental explants were prepared from term non-laboured placentas and treated with 0, 0.4, 4 
and 40 ng/ml dexamethasone in the presence of various TLR ligands. Supernatants were 
harvested after 20 - 24 hours and IL-6 production in response to PGN, Poly (I:C), LPS or flagellin 
determined by ELISA (n = 3; mean ± SEM). Statistical significance as determined by Friedmans 
test with Dunn multiple comparison posthoc test; *<0.05. (b) Unstimulated and LPS stimulated 
IL-6 (pg/ml; mean ± SEM) by gestational age groups: < 32 weeks (n = 4), 32 to <37 weeks (n = 
6), and >37 weeks (n = 12).   
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Case Number 
Gestation in 
weeks 
Mode of delivery Reason for delivery Evidence of infection 
1 25 SVD IAPTL Funisitis 
2 26 SVD IAPTL Urinary infection 
3 27 SVD IAPTL Raised White cell count 
4 31 SVD IAPTL None 
5 33 SVD IAPTL GBS on swabs 
6 33 SVD IAPTL 
Histologic 
Chorioamnionitis 
7 34 SVD IAPTL Raised CRP 
8 36 SVD IAPTL Coliforms on swabs 
9 36 SVD IAPTL Raised White cell count 
10 36 SVD IAPTL Urinary infection 
11 35 SVD (induced) Pre eclampsia None 
12 32 Caesarean Pre eclampsia None 
13 31 Caesarean IUGR None 
14 33 Caesarean IUGR None 
15 36 Caesarean Maternal Glaucoma None 
 
 
Table 1. Characteristics of preterm samples.  
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Table 2. Specifications for qPCR.  
*SDHA-Succinate dehydrogenase complex, subunit A;  
TBP- TATA box binding protein;  
YWHAZ- Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptid
cDNA Forward primer Reverse primer 
Fragment 
size 
Primer 
concentration Mg
++
 
Annealing 
temperature 
F R 
TLR-1 5’-CAGTGTCTGGTACACGCATGGT-3’ 5’-TTTCAAAAACCGTGTCTGTTAAGAGA-3’ 104 5µM 5µM 3mM 60 
TLR-2 5’-GGCCAGCAAATTACCTGTGTG-3’ 5’-AGGCGGACATCCTGAACCT-3’ 67 5µM 5µM 3mM 62 
TLR-3 5’-CCTGGTTTGTTAATTGGATTAACGA-3’ 5’-TGAGGTGGAGTGTTGCAAAGG-3’ 82 5µM 5µM 3mM 57 
TLR-4 5’-CAGAGTTTCCTGCAATGGATCA-3’ 5’-GCTTATCTGAAGGTGTTGCACAT-3’ 88 5µM 5µM 3mM 56 
TLR-5 5’-TGCCTTGAAGCCTTCAGTTATG-3’ 5’-CCAACCACCACCATGATGAG-3’ 77 5µM 5µM 3mM 56 
TLR-6 5’-GAAGAAGAACAACCCTTTAGGATAGC -3’ 5’-AGGCCAAACAAAATGGAAGCTT-3’ 88 5µM 5µM 3mM 56 
TLR-7 5’-TTTACCTGGATGGAAACCAGCTA-3’ 5’-TCAAGGCCTGAGAAGCTGTAAGCTA-3’ 73 5µM 15µM 3mM 59 
TLR-8 5’-TTATGTGTTCCAGGAACTCAGAGAA-3’ 5’-TAATACCCAAGTTGATAGTCGATAAGTTTG-3’ 83 5µM 5µM 3mM 56 
TLR-9 5’-GGACCTCTGGTACTGCTTCCA-3’ 5’-AAGCTCGTTGTACACCCAGTCT-3’ 151 5µM 5µM 3.5mM 61.2 
TLR10 5’-TGTTATGACAGCAGAGGGTGATG-3’ 5’-GAGTTGAAAAAGGAGGTTATAGGATAAATC-3’ 151 5µM 5µM 3mM 56 
SDHA
* 
5’-TGGGAACAAGAGGGCATCTG-3’ 5’-CCACCACTGCATCAAATTCATG-3’ 86 5µM 5µM 3mM 60 
TBP
*
 5’-TGCACAGGAGCCAAGAGTGAA-3’ 5’-CACATCACAGCTCCCCACCA-3’ 132 5µM 5µM 3mM 63 
YWHAZ
*
 5’-ACTTTTGGTACATTGTGGCTTCAA-3’ 5’-CCGCCAGGACAAACCAGTAT-3’ 94 5µM 5µM 3mM 63 
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Figure 1 (a-h) 
(a)
(b)
(c)
(d)
(e)
(f) (g)
p = 0.221 p = 0.003 p = 0.088
p = 0.004 p = 0.003 p = 0.564
p = 0.014 p = 0.0001 p = 0.841
p = 0.315 p = 0.796 p = 0.088
p = 0.008 p = 0.015 p = 0.514
p = 0.001 p = 0.290
p = 0.02
(h)
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(a)   (b)    (c) 
                      
 
 (d)   (e)    (f) 
                     
 
 (g)   (h)    (i) 
                        
 
    (j) 
   
Figure 2 (a-j) 
  
PT
1.50
1.00
0.50
0.00
TL
R
1
p=0.570
PT
3.00
2.50
2.00
1.50
1.00
0.50
0.00
TL
R
2
p=0.570
PT
3.00
2.50
2.00
1.50
1.00
0.50
0.00
TL
R
3
p=0.570
PT
2.50
2.00
1.50
1.00
0.50
0.00
TL
R
4
p=0.887
PT
1.40
1.20
1.00
0.80
0.60
0.40
0.20
0.00
TL
R
5
p=0.570
PT
1.50
1.25
1.00
0.75
0.50
0.25
0.00
TL
R
6
p=0.887
PT
2.00
1.50
1.00
0.50
0.00
TL
R
7
p=0.831
PT
2.50
2.00
1.50
1.00
0.50
0.00
TL
R
8
p=0.570
PT
2.00
1.50
1.00
0.50
0.00
TL
R
9
p=0.286
PT
1.50
1.00
0.50
0.00
TL
R
10
p=0.088
 21 
 
 
Figure 3 (a-d) 
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Figure 4 (a & b) 
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